This implies that NRF2/KEAP1 pathway is an essential therapeutic target in a wide range of diseases in which inflammation and oxidative stress have been implicated such as Parkinson’s disease, Alzheimer’s disease, diabetes, osteoporosis, atherosclerosis, rheumatoid arthritis, septic shock and many others. This evidence concerns the gene KEAP1 and osteoporosis.